ad35 investigational hiv vaccine
Vaccineexperimental
Clinical trial activity
1 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2011 (NCT01264445)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ad35 investigational hiv vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01264445 | Phase 1 | Feb 1, 2011 | GlaxoSmithKline, International AIDS Vaccine Initiative, Kenya AIDS Vaccine Initiative, Medical Research Council-UVRI Uganda Research Unit on AIDS, Uganda Virus Research Institute, Zambia-Emory HIV Research Project |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 1 | 0 | 1 | 2011 |
| International AIDS Vaccine Initiative | Academic/Hospital | 1 | 1 | 1 | 2011 |
| Kenya AIDS Vaccine Initiative | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Medical Research Council-UVRI Uganda Research Unit on AIDS | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Uganda Virus Research Institute | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Zambia-Emory HIV Research Project | Academic/Hospital | 1 | 0 | 1 | 2011 |
6 organizations
Page 1 / 1